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Background: The relationships between higher hemoglobin (Hb) and the risk of higher metabolic syn-
drome (MetS) are important. However, most studies did not exclude individuals who were taking
medications for MetS components, which would obviously lead to underestimations. At the same time,
geriatric medicine is an important issue in our society. The aim of the present study is to determine the
relationships between Hb and MetS components in the elderly, after excluding those individuals who
were on medication for MetS.
Methods: Individuals aged older than 65 years were randomly selected from a health center between
1999 and 2008. After excluding those with medications for hypertension, hyperlipidemia, and/or dia-
betes, 3252 individuals were eventually included in the analysis.
Results: The levels of Hb increased with the increasing percentage of MetS. In multivariate analysis, both
fasting plasma glucose and high-density lipoprotein cholesterol fail to show signiﬁcance in both sexes. In
addition, in men systolic blood pressure (BP) is not correlated with Hb. The odds ratio is 1.915 in men and
2.088 inwomenwhen the highest Hb group is comparedwith the lowest Hb group (p< 0.001 in both sexes).
Conclusion: Higher Hb was associated with increased chances of having MetS in elderly adults. The most
important contributors are waist circumference, BP, and low-density lipoprotein cholesterol for both men
and women.
Copyright © 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Because of the improvement of the healthcare system in Taiwan
as well as in many other countries, human life expectancy has
considerably increased; thus, aging has already become a serious
challenge. Among these aged people, cardiovascular disease (CVD)
is always among the top ﬁve causes of death. Metabolic syndrome
(MetS) refers to a group of factors that increases an individual's risk
of developing CVD. CVD not only causes deterioration in quality of
life but also increases the economic burden to society. Therefore,
early detection of MetS in elderly individuals is an urgent issuere that they have no conﬂicts
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es/by-nc-nd/4.0/).because MetS is manageable and can reduce the risk of developing
future CVD without serious complications. As early as 1964, Ava-
garo et al1 ﬁrst reported the phenomenon of clustering of adiposity,
hypertension, dyslipidemia, and glucose intolerance. Subsequently,
this phenomenonwas thought to be related to insulin resistance in
19882. It eventually attracted the attention of the World Health
Organization and was termed “MetS”.3 However, more than 40
deﬁnitions have been proposed by different societies and used in
studies around the world. To resolve this situation, the consensus
deﬁnition of MetS was ﬁnally made in 20094. The factors in the
MetS deﬁnition were called “traditional factors.” In addition, there
were many “nontraditional” factors that were shown to be associ-
ated with MetS in several studies, including uric acid, fatty liver,
and inﬂammatory markers5,6.
As noted earlier, the core of MetS is insulin resistance7. Other
than this, low-grade inﬂammation is also considered to contribute
to the underlying pathophysiology8. Among them, for instance,
white blood cell count is one of the ﬁrst inﬂammatory markers that
was proposed to be associated with MetS9e11. Other hematogramicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC
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have this relationship7,12,13. Although several reports have shown a
positive correlation between Hb and MetS, all of them did not
exclude patients who were under treatment for hypertension, hy-
perglycemia, and/or dyslipidemia. It is important to note that these
components are the observational variables. Taking such medica-
tions will certainly be a confounding interference for these studies.
Therefore, the true relationships between Hb and MetS still remain
to be elucidated.
Because of insufﬁcient evidence on the true relationship be-
tween Hb and MetS components not affected by medication con-
founders and, at the same time, considering that geriatric medicine
is important, the purpose of the present study was to shed light on
the relationships between Hb and MetS components in elderly
individuals whowere not takingmedicines forMetS components at
the time of the study.
2. Materials and methods
2.1. Study participants
This cross-sectional study enrolled individuals aged > 65 years
who were receiving an annual health examination at the MJ Life
Clinic, a large institute that offers routine health examination in
north, central, and south Taiwan as well as in China. The Institu-
tional Review Board of MJ Life Clinic approved the study protocol,
and all participants provided informed consent.
Initially, a total of 8698 nonrepeated elderly individuals during
the period between 1999 and 2008 were randomly selected from
the clinic's database. The randomizationwas by the ﬁrst 870 elderly
individuals in each year (from 1999 to 2008) in the MJ database.
Individuals with major diseases such as diabetes and hypertension,
or those taking medications for hyperlipidemia, hypertension, or
diabetics were all excluded. These stringent exclusion criteria were
used in order to determine the true relationships between Hb and
each component of MetS. Thus, 5281 individuals were excluded.
Another 281 individuals were further excluded owing to missing
data on the components of MetS (Figure 1).
In order to evaluate and deﬁne the relationships more clearly,
only those with normal levels of Hb were included (12.5e16.5 g/dL
in men and 11.5e14.5 g/dL according to MJ Life Clinic's normal
references). Finally, 3252 individuals were included for analysis.
2.2. Anthropometric measurements and general data
The participants presented at the clinic at 8:00 AM after at least
10 hours of fasting. Senior nursing staff obtained information on
medical history, lifestyle, alcohol intake, smoking, and physical
exercise. Physicians performed complete physical examinations
and measured the waist circumference (WC). Both systolic blood
pressure (SBP) and diastolic blood pressure (DBP) were measured
twice after at least 5 minutes of rest using standard sphygmoma-
nometers. Blood samples for biochemistry study were drawn from
the antecubital vein.
2.3. Laboratory measurements
Plasma was separated from blood within 1 hour after extraction
and then stored at 70C until analysis. The samples are analyzed
for plasma glucose and lipid levels. Fasting plasma glucose (FPG)
was examined using the glucose oxidase method (YSI 203 glucose
analyzer; Scientiﬁc Division, Yellow Spring Instrument Company,
Yellow Spring, OH, USA). Triglyceride (TG) and total cholesterol
were measured with the dry, multilayer analytical slide method in
the Fuji Dri-Chem 3000 analyzer (Fuji Photo Film, Minato-Ku,Tokyo, Japan). Serum high-density lipoprotein cholesterol (HDL-
C) and low-density lipoprotein cholesterol (LDL-C) concentrations
were measured using enzymatic cholesterol assay following
dextran sulfate precipitation, whereas Hb was measured using an
Abbott Cell Dyn 3000 hematology analyzer (Abbott Laboratories,
Abbott Park, IL, USA).
2.4. Deﬁnition of MetS
The latest harmonized criteria of MetS in 20094 were used, with
one modiﬁcationdwherein the criterion forWCwas set to 90 cm
and 80 cm for Taiwanesemen andwomen, respectively14. The other
four criteria were the same: SBP  130 mmHg or DBP  85 mmHg,
TG 150mg/dL, FPG 100mg/dL, and HDL 40mg/dL and 50mg/
dL in men and women, respectively. Individuals must meet at least
three criteria to be diagnosed with MetS.
2.5. Statistical analysis
The data were analyzed using the SPSS version 18.0 (SPSS Inc.,
Chicago, IL, USA). All data were tested for normal distribution
using KolmogoroveSmirnov test and for homogeneity of variances
by Levene's test. Continuous variables were expressed as
mean ± standard deviation. The t test was used to evaluate dif-
ferences between the two groups. According to the levels of Hb,
the participants were classiﬁed into quartiles. When comparing
the differences among these four groups, one-way analysis of
variance was used. For post hoc comparison, the Bonferroni test
was applied. To observe correlations among different parameters,
simple correlation and multivariate linear regression were used.
Odds ratio (OR) was calculated by logistic regression model to
compare the possibility of having MetS in different groups. All
statistical tests were two-sided. Statistical signiﬁcance was set at
p < 0.05.
3. Results
3.1. Demographic data of study population
A total of 3252 elderly individuals were enrolled in the current
study, comprising 1799 men and 1453 women. The mean age is
70.1 years for men and 69.7 years for women. Table 1 shows the
demographic data of the study population with and without MetS.
Not surprisingly, all MetS components are higher in individuals
with MetS. Moreover, the age in both sexes shows no signiﬁcant
differences. However, LDL-C shows signiﬁcant differences only in
elderly women. In addition, Hb is signiﬁcantly higher in the group
with MetS regardless of sex with p < 0.001.
3.2. Hb and components of MetS
We divided the study participants into quartiles according to
the Hb level. Among the four quartiles (from the lowest to highest
Hb, Hb1 to Hb4), the trends of almost all MetS components are
found to be correlated with Hb. Higher Hb level had higher levels
of WC, SBP, DBP, FPG, total cholesterol, and LDL-C (Table 2).
Although the trend seems to have a positive relationship with SBP
and Hb in males, it still did not reach signiﬁcance. HDL-C de-
creases as Hb increases in men, with statistical signiﬁcance, but
this effect was not observed in women. Another interesting
ﬁnding is age. As men get older, their Hb level falls. An inverse
correlation is seen, but not in women.
Subsequently, we further analyzed the correlation between
MetS components and Hb in the linear regression model. After
univariate and multivariate analyses (Table 3), SBP remained
Figure 1. Description of the study population. F ¼ female; M ¼ male.
Table 1
Anthropometric and metabolic variables of individuals with and without metabolic
syndrome.
Met() Met(þ) p
Male
N 1339 460
Age (y) 70.2 ± 4.4 70.0 ± 4.3 0.494
Waist circumference (cm) 81.6 ± 7.5 90.8 ± 7.6 <0.001
Systolic blood pressure (mmHg) 131 ± 20.6 143 ± 20.1 <0.001
Diastolic blood pressure (mmHg) 74 ± 11.5 80 ± 11.3 <0.001
Fasting plasma glucose (mg/dL) 100.5 ± 20.4 118.9 ± 35.6 <0.001
Total cholesterol (mg/dL) 203.1 ± 37.6 207.5 ± 40.1 0.032
HDL-C (mg/dL) 49.0 ± 13.5 35.2 ± 9.8 <0.001
LDL-C (mg/dL) 133.6 ± 33.1 135.2 ± 36.1 0.399
Triglyceride (mg/dL) 102.9 ± 43.3 185.8 ± 71.0 <0.001
Hemoglobin (g/dL) 14.4 ± 1.36 14.7 ± 1.31 <0.001
Female
n 956 497
Age (y) 69.6 ± 4.2 69.8 ± 4.3 0.390
Waist circumference (cm) 74.8 ± 7.0 82.5 ± 7.6 <0.001
Systolic blood pressure (mmHg) 137.7 ± 22.0 149.6 ± 20.7 <0.001
Diastolic blood pressure (mmHg) 76.0 ± 12.0 80 ± 11.6 <0.001
Fasting plasma glucose (mg/dL) 103.6 ± 29.4 112.5 ± 32.4 <0.001
Total cholesterol (mg/dL) 217.5 ± 39.7 223.7 ± 40.9 0.005
HDL-C (mg/dL) 56.9 ± 14.2 42.3 ± 11.2 <0.001
LDL-C (mg/dL) 138.6 ± 35.2 144.0 ± 35.6 0.005
Triglyceride (mg/dL) 110.0 ± 46.7 187.5 ± 70.8 <0.001
Hemoglobin (g/dL) 13.0 ± 1.1 13.3 ± 1.1 <0.001
Data are presented as mean ± standard deviation.
HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein
cholesterol; TG ¼ triglyceride.
Y.-H. Hu et al.24nonsigniﬁcant in men, which is consistent with the previous
ﬁnding. In addition, HDL-C did not reach signiﬁcance in both men
and women after multivariate analysis. Surprisingly, FPG showed
no correlation with Hb after multivariate analysis. This means FPG
is not an independent factor that correlates with Hb in both sexes.3.3. Clinical implications of Hb and MetS
As can be seen in Figure 2, the MetS percentage increases
sharply at 13 g/dL in men and 10 g/dL in women. By the logistic
regression test, the OR becomes higher in the group with the
highest Hb (Table 4). The OR is 1.113, 1.539, and 1.915 in men and
1.501, 1.411, and 2.088 in women when compared with the lowest
Hb group (Hb1). The p value is < 0.001 when the highest Hb group
(Hb4) is compared with the lowest Hb group (Hb1) in both sexes.4. Discussion
The current study demonstrates that Hb is associated with MetS
in the elderly. In both sexes, the highest OR of having MetS was in
the group with the highest Hb level (Hb4). By and large, our ﬁnd-
ings are consistent with the results of other major studies15e17.
From the results of multiple regression, which could observe the
“independent” relationships between each parameters, it could be
noted that FPG and HDL-C did not correlate with Hb in either men
or women. Moreover, SBP was also not signiﬁcantly associated with
Hb in men. These results are not consistent with the ﬁndings of
previous studies. For instance, Nebeck et al17 found that FPG and
HDL-C were signiﬁcantly correlated with Hb in women. Similarly,
Lohsoonthorn et al18 examined healthy ofﬁce people in Thailand,
and their results also did not show any correlation between Hb and
MetS in men. Nonetheless, these studies had threemain differences
compared to the present study that might explain the conﬂicting
results. First, the exclusion criteria in our study were stricter, which
excluded individuals who were taking certain medications. As a
result, the main trends of associations between Hb and MetS are
the same, but each MetS component had somewhat different in-
teractions. Our ﬁndings could further elucidate these relationships.
The second and third factors are old age and large study number. In
Table 2
Components of metabolic syndrome in groups with different hemoglobin levels.
Hb1 Hb2 Hb3 Hb4 p
Male
n 479 463 420 437
Hb (g/dL) 12.9 ± 1.1 14.2 ± 0.2 15.0 ± 0.2 16.0 ± 0.7 <0.001
Age (y) 71.0 ± 5.0 70.1 ± 4.4 69.8 ± 3.8 69.5 ± 4.1 <0.001
WC (cm) 78.7 ± 8.0 79.5 ± 7.4 81.84 ± 7.8 82.9 ± 6.9 <0.001
SBP (mmHg) 133.6 ± 22.8 134.7 ± 20.4 134.3 ± 20.7 135.5 ± 20.5 0.302
DBP (mmHg) 73.2 ± 11.3 75.4 ± 11.9 77.7 ± 11.2 78.2 ± 11.7 <0.001
FPG (mg/dL) 102.8 ± 23.5 104.3 ± 27.2 106.0 ± 25.6 108.0 ± 29.1 0.021
TC (mg/dL) 196.5 ± 39.5 204.5 ± 38.6 204.5 ± 36.0 212.1 ± 37.1 <0.001
HDL-C (mg/dL) 46.8 ± 14.3 45.8 ± 14.1 45.0 ± 14.0 44.0 ± 13.6 0.026
LDL-C (mg/dL) 128.4 ± 34.8 135.3 ± 35.1 134.3 ± 32.5 138.5 ± 32.2 <0.001
TG (mg/dL) 107.2 ± 55.4 117.4 ± 59.7 126.3 ± 60.6 147.7 ± 69.7 <0.001
Female
n 354 368 341 390
Hb (g/dL) 11.7 ± 0.78 12.8 ± 0.2 13.4 ± 0.17 14.4 ± 0.55 <0.001
Age (y) 70.1 ± 4.5 69.5 ± 4.1 69.5 ± 4.1 69.4 ± 4.1 0.780
WC (cm) 74.6 ± 7.3 75.5 ± 7.1 75.7 ± 7.2 76.3 ± 7.9 <0.001
SBP (mmHg) 138.4 ± 21.9 140.9 ± 21.4 142.8 ± 22.0 144.7 ± 23.2 0.001
DBP (mmHg) 74.1 ± 11.7 76.5 ± 11.6 77.3 ± 11.6 80.5 ± 12.2 <0.001
FPG mg/dL) 103.4 ± 26.3 105.0 ± 27.1 107.4 ± 30.1 110.5 ± 37.3 0.011
TC (mg/dL) 210.1 ± 40.4 217.3 ± 39.2 222.8 ± 39.5 227.8 ± 39.6 <0.001
HDL-C (mg/dL) 51.4 ± 14.7 51.9 ± 15.3 52.2 ± 14.8 52.2 ± 15.1 0.896
LDL-C (mg/dL) 134.6 ± 36.0 138.6 ± 35.5 143.2 ± 34.1 145.1 ± 35.2 <0.001
TG (mg/dL) 120.7 ± 61.6 134.2 ± 67.9 137.7 ± 63.9 152.1 ± 70.4 <0.001
Data are presented as mean ± standard deviation.
DBP ¼ diastolic blood pressure; FPG ¼ fasting plasma glucose; Hb ¼ hemoglobin; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein cholesterol;
SBP ¼ systolic blood pressure; TC ¼ total cholesterol; TG ¼ triglyceride; WC ¼ waist circumference.
Table 3
Univariate and multivariate regression analyses between hemoglobin and each
metabolic syndrome component.a
Univariate Multivariate
b p r p
Male
Waist circumference 0.209 <0.001 0.147 <0.001
Systolic blood pressure 0.117 <0.001 0.062 0.176
Diastolic blood pressure 0.218 <0.001 0.202 <0.001
Fasting plasma glucose 0.097 <0.001 0.036 0.394
High-density lipoprotein 0.047 0.071 d d
Low-density lipoprotein 0.124 <0.001 0.059 0.022
Triglyceride 0.148 <0.001 0.257 0.007
Female
Waist circumference 0.254 <0.001 0.199 <0.001
Systolic blood pressure 0.056 0.017 0.127 <0.001
Diastolic blood pressure 0.184 <0.001 0.202 <0.001
Fasting plasma glucose 0.095 <0.001 0.023 0.316
High-density lipoprotein 0.055 0.020 0.021 0.322
Low-density lipoprotein 0.142 <0.001 0.109 <0.001
Triglyceride 0.222 <0.001 0.156 <0.001
BMI ¼ body mass index.
a The multivariant regression analysis was built by the signiﬁcant metabolic
syndrome components and low-density lipoprotein. In addition, age and BMI are
also adjusted.
Figure 2. Prevalence of metabolic syndrome according to hemoglobin levels.
Hemoglobin and Components of Metabolic Syndrome 25the study by Lohsoonthorn et al18, the study participants were
healthy and the study population was relatively small. These two
factors may account for the differences in results.
The relationship between BP and Hb has been reported in
several studies19e23. Atsma et al19 reported that Hb was positively
associated with BP in a large cohort of 101,377 healthy donors of
whole blood and plasma. Similar results were seen in DBP. More-
over, G€obel et al20 reported that Hb was signiﬁcantly correlated not
only with SBP and DBP but also with mean arterial BP. The possible
mechanisms may be attributable to the effects of insulin on
erythropoiesis, which activates tyrosine kinase in the insulin re-
ceptor that is essential for the growth-promoting action of insulin11.
Second, increased Hb/red blood cell levels leading to an elevated
release of oxygen from the organs could also contribute24.The relationship between Hb and FPG has been intriguing. As
early as 1998, Facchini et al25 found that Hb was signiﬁcantly
related to insulin resistance by measuring the precise steady-state
plasma glucose concentration. Kutlu et al26 also demonstrated that
CD40 ligand might be the link between Hb and prediabetes. The
possible mechanism is that Hb could regulate endothelial function
bymodulating the bioavailability of nitric oxide at the tissue level27.
The results in our study showed a positive correlation between Hb
and FPG in both Hb quartile trend and univariate regression
regardless of sex. However, this correlation became insigniﬁcant
after multivariate analysis. This may be explained by the possibility
that Hb might be indirectly related to FPG in the elderly.
It has been reported that levels of Hb and copper concentra-
tions are associated with cholesterol concentrations28. In mouse
and human models of atherosclerosis, Hb contributes to the in-
ﬂammatory nature of HDL-C29. Furthermore, HDL-C is related with
Table 4
Prevalence and odds ratios of metabolic syndrome in different hemoglobin levels.
Hb1 Hb2 Hb3 Hb4
Male
Prevalence 20.7 22.5 28.6 33.4
Odds ratio 1 (Ref) 1.113
(0.814e1.522)
1.539
(1.131e2.094)
1.915
(1.420e2.584)
p d 0.504 0.006 <0.001
Female
Prevalence 25.9 34.5 33.1 42.3
Odds ratio 1 (Ref) 1.501
(1.089e2.067)
1.411
(1.017e1.958)
2.088
(1.530e2.850)
p d 0.013 0.039 <0.001
Hb ¼ hemoglobin.
Y.-H. Hu et al.26Hb in the form of OxyHb. The main focus of this particle is on
proinﬂammatory HDL-C, which consumes nitric oxide and could
cause arterial vessel contraction. However, Hb is also differentially
associated with HDL-C in individuals with or without coronary
heart disease29,30. All these factors could contribute to our ﬁnding
of the nonsigniﬁcant relationship between HDL-C and Hb in
elderly women.
In the present study, both WC and TG were associated with Hb.
This ﬁnding is consistent with the results of other major studies
conducted in different age groups15e17. The relationship between
WC and Hb is not difﬁcult to expect. It is well known that increased
WC could cause Insulin resistance (IR), which is also related to low-
grade inﬂammation31. This inﬂammation could elevate Hb. Thus,
increased WC could eventually have an effect on the level of Hb. At
the same time, low-grade inﬂammation is also a mediator for the
correlation between TG and Hb. The fact that postprandial hyper-
triglyceridemia could cause the increase of ICAM-1 and VCAM-1,
which are markers of chronic inﬂammation, supports this
hypothesis32.
The strength of the current study is the removal of medications
as confounders, and we conclude that higher Hb is associated with
higher risk of developing MetS. Although the ﬁnal results were
similar between our study and other previous studies not excluding
medications, the correlation between components of MetS and Hb
is different. For example, Nebeck et al17 found that FPG is signiﬁ-
cantly correlated with Hb in women, but this was not reﬂected in
our results. This may be because in individuals taking medications,
the true serum FPG concentration may have been “masked,” lead-
ing to an ambiguous result. Still, there are limitations in this study.
First, all of our participants were recruited from the MJ Health
Screening Center in Taiwan, which paid close attention to their
health condition. Consequently, this may pose a selection bias.
Second, because of this, the social economic status of these in-
dividuals might be higher than that of the general population,
which is also a confounding factor. Lastly, this is a retrospective
study. Further prospective studies are warranted to further validate
the ﬁndings here.
In conclusion, Hb was associated with increased chance of
having MetS in elderly adults. The most important contributors
were WC, DBP, LDL, and TG for men and WC, SBP, DBP, LDL, and TG
for women.
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